Vascular Stents Market is expected to register 7.7% CAGR during the forecast period of 2019 to 2025, with a market value of USD 16788.9 Million in 2018.

The most important market driver for the global vascular stents market growth is increasing the prevalence of cardiovascular diseases, along with coronary diseases. Vascular stents are used to unblock arteries by removing the deposited plaque, which is mainly cholesterol or fat. This removal ensures free flow of blood through those arteries. The changing lifestyle can result in the market growth as consumers are more prone to different vascular diseases due to adoption of deskbound work life, lack of exercise, and poor diet. Other factors ensuring the market growth include advances in the treatment of the vascular diseases, increase in number of angioplasty procedures, and increasing obese population. However, factors that slow down the market growth include high cost of the vascular stents and availability of alternative therapies.

Market Segmentation

The global vascular stents market segmentation encompasses application, end-user, and type. MRFR’s take on the market surveys various facets of the market in-depth.

The application-based segmentation of this market covers coronary artery, peripheral artery, and others. In the context of end-user, the market has been segmented into ambulatory centers, clinics, and hospital. By type, the market has been segmented into balloon expanding the stent, drug-eluting stent, renal artery stents, self-expanding stent, and other.

Regional Segmentation

A geographical outlining of the global vascular stents market covers the Americas (North America South America), Europe, Asia Pacific, and the Middle East Africa (MEA).

The Americas is the largest regional market as North America alone holds the potential of being the largest regional market. Due to technological advancement and the presence of key market players, North America is a greater market than South America. North America is a strong market due to lack of exercise, increasing obese population, availability of advanced medical facilities, and increasing people suffering from various cardiovascular diseases. USA and Canada generate the maximum revenue in the market.

Europe is the second-largest regional market due to the high density of population, technological advancement, availability of funds for research development (RD) activities, availability of advanced medical facilities, and presence of some key market players. The most powerful country-specific markets in Western Europe are France, Germany, Italy, Spain, and the UK.

During the forecast period, the Asia Pacific region can be the fastest growing regional market due to rapid development in technology, high density of population, improving healthcare sector, and a huge pool of patients suffering from different vascular diseases. The remarkable country-specific markets in this region are Australia, China, India, Japan, and South Korea.

The MEA is the smallest regional market due to limited development in the medical sector. Some country-specific markets that are better than most of the markets are Kuwait, Oman, Qatar, Saudi Arabia, and UAE.

Key Players

Big players in the global vascular stents market include Abbott Laboratories (USA), B. Braun Melsungen AG (Germany), Biotronik SE Co. Kg (Germany), Boston Scientific Corporation (USA), Cook Medical (USA), Cordis (USA), Lombard Medical Technologies (UK), Medtronic PLC (UK), Meril Life Sciences Pvt. Ltd. (India), MicroPort Scientific Corporation (China), Terumo Corporation (Japan), Translumina GmbH (Germany), Vascular Concepts (India), and W.L. Gore Associates (USA).